Market Overview

Sterne Agee Initiates Boston Scientific At Neutral

Share:
Related BSX
Boston Scientific Buys Cosman Medical To Expand Therapeutic Options
Barron's Picks And Pans: Arista Networks, Northern Trust, 1-800-Flowers And More
Boston Scientific buys RFA systems maker Cosman Medical (Seeking Alpha)

Sterne Agee initiated coverage on shares of Boston Scientific (NYSE: BSX) with a Neutral rating.

The target price for Boston Scientific is set to $13.50.

Boston Scientific shares have surged 19.76% over the past 52 weeks, while the S&P 500 index has gained 17.38% in the same period.

Boston Scientific's shares dropped 1.07% to close at $12.97 yesterday.

Latest Ratings for BSX

DateFirmActionFromTo
Jun 2016Guggenheim SecuritiesInitiates Coverage onBuy
May 2016BTIG ResearchDowngradesBuyNeutral
Mar 2016NomuraInitiates Coverage onBuy

View More Analyst Ratings for BSX
View the Latest Analyst Ratings

Posted-In: Sterne AgeeInitiation Analyst Ratings

 

Related Articles (BSX)

View Comments and Join the Discussion!